READING, Pennsylvania, June 26 /PRNewswire/ --

EnerSys (NYSE: ENS), the world's largest manufacturer, marketer and distributor of industrial batteries and Accumulateur Tunisie Assad SA ("Assad"), the market leader in automotive batteries in Tunisia and North Africa, announced today the formation of a new joint venture company for the production and sale of industrial batteries. The new company, EnerSys-Assad SARL, will be 51% owned by EnerSys and 49% by Assad.

SAN FRANCISCO, June 26 /PRNewswire/ --

Network operators and ISPs from around the world have cooperated on two new best practice papers addressing technical issues that will help block botnet-induced spam and improve the deliverability of consumers' personal emails. The recommendations for sharing IP address space and for email forwarding were approved at a Messaging Anti-Abuse Working Group (MAAWG) meeting in Heidelberg, Germany last week and are available today.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070124/CLW180LOGO )

PARIS and CUPERTINO, California, June 26 /PRNewswire/ --

- Investments From Techfund and Credit Agricole Private Equity Validates Miyowa's Leadership in the Mobile Applications Market and Aids in Expansion to the U.S. and Singapore

COLUMBIA, Maryland, June 26 /PRNewswire/ --

Martek Biosciences (Nasdaq: MATK) announced today that life'sDHA(TM), its patented, vegetarian form of DHA-omega 3 essential for infant brain and eye development, is now available to Eastern European consumers in the new Pregnium prenatal supplement from Walmark. Featuring 200 mg per serving of life'sDHA, Pregnium is available at major retailers in the Czech Republic, Slovakia and Romania.

We read (and write here) a lot about gender issues in the scientific arena but usually topics are related to science education and promoting greater equality of numbers at the higher levels. There are a number of studies detailing the issues women face in a predominantly male science world but a University of Missouri religion professor has found that if the researcher is a male fieldworker studying women, the situation can be just as challenging.

His conclusions about male researchers studying female subjects are based on his extensive observations of the Diola (pronounced joe-la) people. Robert M. Baum, professor of religious studies in the College of Arts and Science has been traveling to southwestern Senegal on the African continent and conducting field research among the Diola communities, approximately 600,000 people, for more than 30 years. The modern Diola are primarily rice farmers.

Initially, Baum's work focused on pre-colonial Diola religious history during the era of the Atlantic slave trade, a period when there were male prophets. Later in his research, Baum studied the work and influence of Diola female prophets who began appearing after the French and Portuguese conquest of Diola lands in the late 1800s.

ALTRINCHAM, England, June 26 /PRNewswire/ -- ITIS Holdings plc, a UK Market-leader in real-time traffic information today announces the immediate availability of Next Generation Traffic Services over DAB.

Cars and Personal Navigation devices fitted with DAB TPEG Receivers are now able to receive the most up-to-date traffic information in the London area and nationally thereafter.

As Europe's first RDS-TMC broadcaster, today's announcement further extends ITIS' innovative and market-leading reputation.

ROCKVILLE, Maryland, June 26 /PRNewswire/ --

Pinnacle Biologics, a private, full service pharmaceutical and biotech solutions company, today announced that it has entered into a preferred stock purchase transaction with MedImmune, LLC, pursuant to which MedImmune has acquired certain unspecified number of preferred stock shares of Pinnacle Biologics, Inc. The terms of the agreement were not disclosed.

Pinnacle Biologics owns the marketing and distribution rights to MedImmune's Ethyol(R), 50 mg/ml, powder for solution for infusion in Western Europe, Turkey and Israel.

"This is a highpoint for Pinnacle, as it signifies an additional milestone for our company," said Guillermo Herrera, Chairman of the Board of Pinnacle Biologics.

About Pinnacle Biologics

BASEL, Switzerland, June 26 /PRNewswire/ --

- Roche Also Announces Start of NCORE Study to Determine Best Length of Treatment in Patients who do not Experience a Rapid Response

Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40 KD)) plus Copegus (ribavirin) for certain hepatitis C patients.

PRINCETON, New Jersey, June 26 /PRNewswire/ --

Impliant, Inc., a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that it has resumed European clinical activities on its TOPS(TM) System, a Total Posterior Arthroplasty device designed to treat spinal stenosis with or without facet arthrosis and spondylolisthesis. The procedure was performed by the Lead Clinician of the London Spine Clinic, Mr. John C. Sutcliffe, MB ChB, FRCS.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO )

JERUSALEM and NEEDHAM, Massachusetts, June 26 /PRNewswire/ -- Oridion Systems Ltd. - (SWX: ORIDN) Oridion Medical, the leading developer and manufacturer of innovative capnography monitoring solutions, announced that it won the 2008 Manufacturers Partnership Award from IMDA, the association of medical specialty sales and marketing companies. With this award, IMDA acknowledges the Company's achievements in market development and support of its Specialty distributors (part of the Oridion Distribution Network) to increase their sales of Oridion capnography products.